2-Fucosyllactose
Useful mainly for people wanting a bifidogenic prebiotic; used in infant formula to mimic breast milk.
Quick decision guide
May help most
people wanting a bifidogenic prebiotic; used in infant formula to mimic breast milk
Common dosing range
~1-5 g/day in adult studies; lower amounts in infant formula
When to expect effects
Weeks (microbiome shifts)
Watch out for
may cause gas/bloating at higher doses; adult clinical evidence is early
What is it
2'-Fucosyllactose (2'-FL) is the most abundant human milk oligosaccharide (HMO), a non-digestible sugar that human infants receive through breast milk. Now produced by microbial fermentation, it acts as a prebiotic that selectively feeds beneficial gut bacteria, especially Bifidobacterium, and is added to some infant formulas and adult gut-health products.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
bifidobacterium-promoting prebiotic effect Good Evidence | Shifts gut microbiota toward Bifidobacterium | infants (in formula) and adults seeking a bifidogenic prebiotic | Weeks |
bifidobacterium-promoting prebiotic effect
- Effect
- Shifts gut microbiota toward Bifidobacterium
- Best fit
- infants (in formula) and adults seeking a bifidogenic prebiotic
- Time
- Weeks
Evidence for 1 use
AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.
bifidobacterium-promoting prebiotic effect
Biomarker support2'-FL reliably acts as a selective substrate for Bifidobacterium and is generally well tolerated in adult dosing studies, producing measurable microbiome shifts. In infants, HMO-supplemented formula moves the gut flora and some immune markers closer to those of breastfed babies. Evidence for downstream clinical benefits (e.g. symptom relief, infection reduction) in adults remains early and is mostly biomarker-level.
Bottom line: A well-characterized bifidogenic prebiotic; microbiome effects are clear, but adult clinical benefits are still preliminary.
How to take it
What to track
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Who should avoid it
- people who react poorly to fermentable oligosaccharides (e.g. some with IBS)
Pregnancy & breastfeeding
Considered low-risk as it is identical to a component of human milk, but supplemental use in pregnancy is not specifically studied.
Choosing a product
What to look for on the label — and what to be skeptical of.
Look for…
Be skeptical of…
References by claim
bifidobacterium-promoting prebiotic effect
Lazarini et al., 2025 — PMC (2025) link
Track 2-Fucosyllactose with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.
Coming to App StoreDisclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.